High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer

被引:7
作者
Li, Jianlong [1 ]
Wang, Longwang [1 ]
Xiao, Ruihai [1 ]
Pan, Qiufeng [1 ]
Huang, Hongwei [1 ]
Kuang, Renrui [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Urol, Nanchang 330006, Jiangxi, Peoples R China
关键词
COP1; expression; Bladder cancer; Prognosis; NEGATIVE REGULATOR; P53; RECURRENCE; PROGRESSION; MARKERS;
D O I
10.1007/s13277-015-4765-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study was to investigate the expression and prognostic value of constitutive photomorphogenic 1 (COP1) in bladder cancer. In our study, real-time quantitative PCR (RT-PCR) was performed to detect 10 pairs of fresh bladder cancer (BCa) and adjacent noncancerous tissues. In addition, immunohistochemistry was utilized to detect the expression of COP1 in 174 clinical bladder cancer samples. What is more, the correlation of COP1 expression and clinicopathological features and clinical outcomes were analyzed. The expression levels of COP1 in clinical bladder cancer were much higher than that in paired adjacent noncancerous tissues (p < 0.0001). High expression of COP1 was closely related with differentiation (p = 0.040) and recurrence (p = 0.001) of patients with bladder cancer. Kaplan-Meier analysis revealed that the expression of COP1 was closely correlated with overall survival (p = 0.048) of bladder cancer, while, recurrence-free survival (p = 0.201). Moreover, Cox multivariate regression analyses showed that COP1 expression was an independent predictor of overall survival (OS; p = 0.027, hazard ratio = 2.127, confidence interval 0.814 to 9.736). Based on our data, the present study suggests that high expression of COP1 may be a novel biological indicator for evaluation of poor prognosis in bladder cancer.
引用
收藏
页码:8917 / 8922
页数:6
相关论文
共 19 条
[1]   New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer [J].
Ather, M. Hammad ;
Nazim, Syed M. .
KOREAN JOURNAL OF UROLOGY, 2015, 56 (08) :553-564
[2]   Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance [J].
Azemar, Marie-Dominique ;
Comperat, Eva ;
Richard, Francois ;
Cussenot, Olivier ;
Roupret, Morgan .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (02) :130-136
[3]   The p53 Paddy Wagon - COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest [J].
Corcoran, CA ;
Huang, Y ;
Sheikh, MS .
CANCER BIOLOGY & THERAPY, 2004, 3 (08) :721-725
[4]   COP1 - A REGULATORY LOCUS INVOLVED IN LIGHT-CONTROLLED DEVELOPMENT AND GENE-EXPRESSION IN ARABIDOPSIS [J].
DENG, XW ;
CASPAR, T ;
QUAIL, PH .
GENES & DEVELOPMENT, 1991, 5 (07) :1172-1182
[5]   COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas [J].
Dornan, D ;
Bheddah, S ;
Newton, K ;
Ince, W ;
Frantz, GD ;
Dowd, P ;
Koeppen, H ;
Dixit, VM ;
French, DM .
CANCER RESEARCH, 2004, 64 (20) :7226-7230
[6]   The ubiquitin ligase COP1 is a critical negative regulator of p53 [J].
Dornan, D ;
Wertz, I ;
Shimizu, H ;
Arnott, D ;
Frantz, GD ;
Dowd, P ;
O' Rourke, K ;
Koeppen, H ;
Dixit, VM .
NATURE, 2004, 429 (6987) :86-92
[7]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[8]   Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression [J].
Jones, A ;
Crew, J .
UROLOGIC CLINICS OF NORTH AMERICA, 2000, 27 (01) :191-+
[9]   High Level of COP1 Expression is Associated with Poor Prognosis in Primary Gastric Cancer [J].
Li, Yuan-fang ;
Wang, Dan-dan ;
Zhao, Bai-wei ;
Wang, Wei ;
Huang, Chun-yu ;
Chen, Yong-ming ;
Zheng, Yan ;
Keshari, Rajiv Prasad ;
Xia, Jian-chuan ;
Zhou, Zhi-wei .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2012, 8 (08) :1168-1177
[10]   Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests [J].
Lokeshwar, VB ;
Schroeder, GL ;
Selzer, MG ;
Hautmann, SH ;
Posey, JT ;
Duncan, RC ;
Watson, R ;
Rose, L ;
Markowitz, S ;
Soloway, MS .
CANCER, 2002, 95 (01) :61-72